Alector, Inc.

Ownership Transactions Reported by 20 Insiders

Symbol
ALEC on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
131 Oyster Point Blvd., Suite 600, South San Francisco, CA

Insiders trading volume in the past year

Alector, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Polaris Venture Management Co. VI, L.L.C. 10%+ Owner $68.2M May 29, 2024
Terrance Mcguire Director, 10%+ Owner $60.7M Sep 11, 2023
Tillman U. Gerngross Director $14.7M Jun 14, 2023
Arnon Rosenthal Chief Executive Officer, Director $7.96M -$512K -6.04% Dec 2, 2024
Robert King Chief Development Officer $3.06M Oct 1, 2022
Sara Kenkare-Mitra President and Head of R&D $1.42M -$269K -15.9% Dec 2, 2024
Robert Paul Chief Medical Officer $1.3M Aug 9, 2021
Gary Romano Chief Medical Officer $880K -$159K -15.3% Dec 2, 2024
Marc Grasso Chief Financial Officer $833K -$150K -15.3% Dec 2, 2024
Shehnaaz Suliman President and COO $570K Dec 10, 2021
David M. Wehner Director $553K Jun 12, 2024
Calvin Yu Vice President, Finance $426K Jul 2, 2021
Louis J. Lavigne Jr Director $390K Jun 12, 2024
Kristine Yaffe Director $343K -$25.3K -6.88% Aug 12, 2024
Paula Hammond Director $305K -$53.2K -14.8% Aug 12, 2024
Elizabeth A. Garofalo Director $294K Jun 12, 2024
Errol B. Desouza Director $286K Mar 19, 2024
Mark Altmeyer Director $286K Mar 19, 2024
Richard Scheller Director $181K -$228K -55.8% Aug 22, 2024
Linda M. Rubinstein Interim Chief Financial Ofcr Sep 8, 2021

Recent Insider Transactions by Companies or Individuals for Alector, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.